TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020 (ESCI, Scopus, TRDizin)
Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.